Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Next scheduled review: November 2026
You hit a weight loss plateau
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
IC del 95%, 0,6%-1,4%) y el uso sostenido de SU (RD, 1,8%
Long-term success is built on the daily routines that support your bodys systems
Some cause fewer side effects
US$ 27.52
US$ 21.47
US$ 23.03
US$ 20.37
US$ 21.27
US$ 22.41
US$ 27.56
